Antigen receptors and somatic hypermutation in B-cell chronic lymphocytic leukemia with Richter's transformation
- PMID: 16818277
Antigen receptors and somatic hypermutation in B-cell chronic lymphocytic leukemia with Richter's transformation
Abstract
Background and objectives: Activation-induced cytidine deaminase is essential for somatic hypermutation and class switch recombination of the immunoglobulin genes in B cells. It has been proposed that aberrant targeting of the somatic hypermutation machinery is instrumental in initiation and progression of B-cell non Hodgkin's lymphomas. In this study, we investigated the B-cell receptor and the role of the somatic hypermutation machinery in B-cell chronic lymphocytic leukemias (B-CLL) prior to and after transformation to a lymphoma of a higher malignancy grade (Richter's transformation).
Design and methods: We investigated the activity of the somatic hypermutation machinery in nine B-CLL and secondary diffuse large B-cell lymphomas by measuring the expression of activation-induced cytidine deaminase, in combination with mutation analysis of immunoglobulin (Ig) and non-Ig genes. Furthermore, the structure of the antigen receptors of B-CLL known to have developed a Richter's syndrome (RS B-CLL) was analyzed by comparing the most variable region of the Ig, the CDR3 region, to CDR3 sequences present in GenBank.
Results: Ig variable heavy chain (IgV(H)) gene studies revealed that Richter's transformation occurs almost exclusively in unmutated B-CLL. Furthermore, activated-induced cytidine deaminase expression and somatic hypermutation activity of most RS B-CLL were found to be higher than those of control (non-transforming) B-CLL. Finally, comparison of the IgVH-CDR3 regions showed a remarkable amino acid sequence homology between two RS B-CLL of our panel and two RS B-CLL described in the literature.
Interpretations and conclusions: The combined findings suggest a role for the Ig gene diversification apparatus during Richter's transformation and show that distinct RS-B-CLL may recognize recurrent antigenic epitopes.
Comment in
-
Antigen receptors and somatic hypermutation in B-cell chronic lymphocytic leukemia with Richter's transformation.Haematologica. 2006 Jul;91(7):867. Haematologica. 2006. PMID: 16818267 No abstract available.
Similar articles
-
IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.Am J Surg Pathol. 2007 Oct;31(10):1605-14. doi: 10.1097/PAS.0b013e31804bdaf8. Am J Surg Pathol. 2007. PMID: 17895764
-
Antigen receptors and somatic hypermutation in B-cell chronic lymphocytic leukemia with Richter's transformation.Haematologica. 2006 Jul;91(7):867. Haematologica. 2006. PMID: 16818267 No abstract available.
-
Hodgkin's disease variant of Richter's syndrome clonally related to chronic lymphocytic leukemia arises in ZAP-70 negative mutated CLL.Med Hypotheses. 2006;66(3):577-9. doi: 10.1016/j.mehy.2005.09.007. Epub 2005 Oct 11. Med Hypotheses. 2006. PMID: 16223567
-
What do somatic hypermutation and class switch recombination teach us about chronic lymphocytic leukaemia pathogenesis?Curr Top Microbiol Immunol. 2005;294:71-89. doi: 10.1007/3-540-29933-5_5. Curr Top Microbiol Immunol. 2005. PMID: 16323428 Review.
-
Somatic hypermutation and B-cell lymphoma.Philos Trans R Soc Lond B Biol Sci. 2001 Jan 29;356(1405):73-82. doi: 10.1098/rstb.2000.0751. Philos Trans R Soc Lond B Biol Sci. 2001. PMID: 11205334 Free PMC article. Review.
Cited by
-
Activation-induced deaminase and its splice variants associate with trisomy 12 in chronic lymphocytic leukemia.Ann Hematol. 2019 Feb;98(2):423-435. doi: 10.1007/s00277-018-3520-5. Epub 2018 Oct 27. Ann Hematol. 2019. PMID: 30368590 Free PMC article.
-
Recent advances in the diagnosis and therapy of Richter's syndrome.Med Oncol. 2007;24(1):17-32. doi: 10.1007/BF02685899. Med Oncol. 2007. PMID: 17673808 Review.
-
IGHV gene rearrangements as outcome predictors for CLL patients: experience of Ukrainian group.Med Oncol. 2012 Jun;29(2):1093-101. doi: 10.1007/s12032-011-9872-5. Epub 2011 Mar 4. Med Oncol. 2012. PMID: 21503826
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources